The genetic aspects of PV have also gained significant attention, particularly the JAK2 gene, with research on JAK2 genetics peaking from 2012 to 2018 and studies on JAK2 antagonists and inhibitors between 2012 and 2017. The gene discussed is JAK2; the disease is acquired polycythemia vera.